$CNO
CNO Financial Group, Inc. Stock $cno

$cno Overview Financials Valuation SEC Filings Company Website

2017 Q4 Form 10-Q Financial Statement

#000122460817000063 Filed on November 01, 2017

Income Statement

Concept	2017 Q4	2017 Q3	2016 Q3
Revenue	$1.090B	$1.079B	$1.016B
YoY Change	8.48%	6.24%	12.32%
Cost Of Revenue		$638.1M	$609.8M
YoY Change		4.64%	4.76%
Gross Profit		$441.2M	$406.1M
YoY Change		8.64%	25.96%
Gross Profit Margin		40.88%	39.97%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$929.3M	$913.8M	$937.2M
YoY Change	17.07%	-2.5%	13.16%
Operating Profit		-$472.6M	-$531.1M
YoY Change		-11.01%	5.0%
Interest Expense	-$31.40M	$30.10M	$29.40M
YoY Change	3.29%	2.38%	23.01%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	$125.4M	$129.9M	$49.30M
YoY Change	-30.6%	163.49%	-5.92%
Income Tax	$196.3M	$29.10M	$30.70M
% Of Pretax Income	156.54%	22.4%	62.27%
Net Earnings	-$70.90M	$100.8M	$18.60M
YoY Change	-130.27%	441.94%	-44.97%
Net Earnings / Revenue	-6.5%	9.34%	1.83%
Basic Earnings Per Share	-$0.42	$0.60	$0.11
Diluted Earnings Per Share	-$0.42	$0.59	$0.11
COMMON SHARES
Basic Shares Outstanding	167.8M shares	168.7M shares	174.2M shares
Diluted Shares Outstanding		171.0M shares	175.7M shares

Balance Sheet

Concept	2017 Q4	2017 Q3	2016 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$757.3M	$871.8M	$706.0M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$27.85B	$27.06B	$26.72B
YoY Change	6.16%	1.24%	8.87%
Other Assets	$367.0M	$567.0M	$607.0M
YoY Change	-53.54%	-6.59%	-29.58%
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$33.11B	$32.70B	$32.42B
YoY Change	3.55%	0.88%	4.55%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt	$3.972B	$3.760B	$4.250B
YoY Change	-5.94%	-11.53%	8.67%
Other Long-Term Liabilities	$752.0M	$789.0M	$730.0M
YoY Change	23.08%	8.08%	-1.22%
Total Long-Term Liabilities	$4.724B	$4.549B	$4.980B
YoY Change	-2.28%	-8.65%	7.1%
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities	$4.724B	$4.549B	$4.980B
Total Liabilities	$28.26B	$27.82B	$27.93B
YoY Change	2.82%	-0.37%	4.05%
SHAREHOLDERS EQUITY
Retained Earnings	$560.4M	$851.9M	$430.3M
YoY Change	-13.88%	97.98%	93.05%
Common Stock	$3.075B	$3.096B	$3.208B
YoY Change	-4.32%	-3.49%	-6.68%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$4.848B	$4.882B	$4.494B
YoY Change
Total Liabilities & Shareholders Equity	$33.11B	$32.70B	$32.42B
YoY Change	3.55%	0.88%	4.55%

Cashflow Statement

Concept	2017 Q4	2017 Q3	2016 Q3
OPERATING ACTIVITIES
Net Income	-$70.90M	$100.8M	$18.60M
YoY Change	-130.27%	441.94%	-44.97%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	$183.8M	$163.5M	$245.1M
YoY Change	3.26%	-33.29%	19.62%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$534.3M	$97.70M	-$46.50M
YoY Change	13.97%	-310.11%	-192.26%
Cash From Investing Activities	-$534.3M	$97.70M	-$46.50M
YoY Change	13.97%	-310.11%	-192.26%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	236.0M	-329.3M	70.20M
YoY Change	270.49%	-569.09%	-173.58%
NET CHANGE
Cash From Operating Activities	183.8M	163.5M	245.1M
Cash From Investing Activities	-534.3M	97.70M	-46.50M
Cash From Financing Activities	236.0M	-329.3M	70.20M
Net Change In Cash	-114.5M	-68.10M	268.8M
YoY Change	-49.58%	-125.33%	68.11%
FREE CASH FLOW
Cash From Operating Activities	$183.8M	$163.5M	$245.1M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	cno	Amortization Related To Investment Gains Losses AmortizationRelatedToInvestmentGainsLosses	900000	USD
	cno	Fair Value Fixed Maturity Securities Valued Using Broker Quotes Percentage FairValueFixedMaturitySecuritiesValuedUsingBrokerQuotesPercentage	0.45
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2016Q4	cno	Accumulated Other Comprehensive Income Adjustment To Insurance Liabilities Due To Unrealized Gains That Would Result In Premium Deficiency If Unrealized Gains Were Realized AccumulatedOtherComprehensiveIncomeAdjustmentToInsuranceLiabilitiesDueToUnrealizedGainsThatWouldResultInPremiumDeficiencyIfUnrealizedGainsWereRealized	-13500000	USD
CY2017Q3	cno	Accumulated Other Comprehensive Income Adjustment To Insurance Liabilities Due To Unrealized Gains That Would Result In Premium Deficiency If Unrealized Gains Were Realized AccumulatedOtherComprehensiveIncomeAdjustmentToInsuranceLiabilitiesDueToUnrealizedGainsThatWouldResultInPremiumDeficiencyIfUnrealizedGainsWereRealized	-224500000	USD
CY2016Q4	cno	Accumulated Other Comprehensive Income Loss Adjustment To Deferred Policy Acquisition Costs AccumulatedOtherComprehensiveIncomeLossAdjustmentToDeferredPolicyAcquisitionCosts	-223500000	USD
CY2017Q3	cno	Accumulated Other Comprehensive Income Loss Adjustment To Deferred Policy Acquisition Costs AccumulatedOtherComprehensiveIncomeLossAdjustmentToDeferredPolicyAcquisitionCosts	-287900000	USD
CY2016Q4	cno	Accumulated Other Comprehensive Income Loss Adjustment To Present Value Of Future Profits AccumulatedOtherComprehensiveIncomeLossAdjustmentToPresentValueOfFutureProfits	-106200000	USD
CY2017Q3	cno	Accumulated Other Comprehensive Income Loss Adjustment To Present Value Of Future Profits AccumulatedOtherComprehensiveIncomeLossAdjustmentToPresentValueOfFutureProfits	-98100000	USD
CY2016Q4	cno	Accumulated Other Comprehensive Income Loss Deferred Income Tax Liabilities AccumulatedOtherComprehensiveIncomeLossDeferredIncomeTaxLiabilities	-345200000	USD
CY2017Q3	cno	Accumulated Other Comprehensive Income Loss Deferred Income Tax Liabilities AccumulatedOtherComprehensiveIncomeLossDeferredIncomeTaxLiabilities	-517200000	USD
CY2016Q4	cno	Accumulated Other Comprehensive Income Loss Net Unrealized Appreciation Depreciation On Fixed Maturity Securities Available For Sale When Other Than Temporary Impairment Loss Was Recognized AccumulatedOtherComprehensiveIncomeLossNetUnrealizedAppreciationDepreciationOnFixedMaturitySecuritiesAvailableForSaleWhenOtherThanTemporaryImpairmentLossWasRecognized	-1100000	USD
CY2017Q3	cno	Accumulated Other Comprehensive Income Loss Net Unrealized Appreciation Depreciation On Fixed Maturity Securities Available For Sale When Other Than Temporary Impairment Loss Was Recognized AccumulatedOtherComprehensiveIncomeLossNetUnrealizedAppreciationDepreciationOnFixedMaturitySecuritiesAvailableForSaleWhenOtherThanTemporaryImpairmentLossWasRecognized	2400000	USD
CY2016Q4	cno	Accumulated Other Comprehensive Income Loss Net Unrealized Gains Losses On All Other Investments AccumulatedOtherComprehensiveIncomeLossNetUnrealizedGainsLossesOnAllOtherInvestments	1311900000	USD
CY2017Q3	cno	Number Of Investments Held By Variable Interest Entities In Default NumberOfInvestmentsHeldByVariableInterestEntitiesInDefault	0	investment
	cno	Number Of Product Distribution Channels NumberOfProductDistributionChannels	3	distribution_channel
	cno	Number Of States Participating In Examination Of Compliance With Unclaimed Property Laws NumberOfStatesParticipatingInExaminationOfComplianceWithUnclaimedPropertyLaws	38	state
CY2017Q3	cno	Numberof Individuals Appointedto Assume Immediate Controland Power Over Affairs NumberofIndividualsAppointedtoAssumeImmediateControlandPowerOverAffairs	2	individual
CY2017Q3	cno	Federal Long Term Tax Exempt Rate FederalLongTermTaxExemptRate	0.0193
	cno	Future Cash Tax Payments As A Percent Of Life Insurance Taxable Income Due FutureCashTaxPaymentsAsAPercentOfLifeInsuranceTaxableIncomeDue	0.65
CY2017Q3	cno	Accumulated Other Comprehensive Income Loss Net Unrealized Gains Losses On All Other Investments AccumulatedOtherComprehensiveIncomeLossNetUnrealizedGainsLossesOnAllOtherInvestments	2058900000	USD
CY2017Q3	cno	Aggregate Growth Rateforthe Next Five Years Includedin Deferred Tax Valuation Analysis AggregateGrowthRatefortheNextFiveYearsIncludedinDeferredTaxValuationAnalysis	0.03
CY2016Q3	cno	Amortization Related To Investment Gains Losses AmortizationRelatedToInvestmentGainsLosses	200000	USD
	cno	Gain Losson Investments Excluding Cash Expenses GainLossonInvestmentsExcludingCashExpenses	23300000	USD
CY2017Q3	cno	Amortization Related To Investment Gains Losses AmortizationRelatedToInvestmentGainsLosses	700000	USD
	cno	Amortization Related To Investment Gains Losses AmortizationRelatedToInvestmentGainsLosses	1000000	USD
CY2017Q3	cno	Available For Sale Fixed Maturities With Significant Unobservable Inputs Investment Grade Percent AvailableForSaleFixedMaturitiesWithSignificantUnobservableInputsInvestmentGradePercent	0.55
CY2017Q3	cno	Available For Sale Maturities With Significant Unobservable Inputs Corporate Securities Percent AvailableForSaleMaturitiesWithSignificantUnobservableInputsCorporateSecuritiesPercent	0.80
CY2016Q4	cno	Available For Sale Securities Debt Maturities Amortized Cost Subtotal AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostSubtotal	14542600000	USD
CY2017Q3	cno	Available For Sale Securities Debt Maturities Amortized Cost Subtotal AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostSubtotal	15206100000	USD
CY2016Q4	cno	Available For Sale Securities Debt Maturities Fair Value Subtotal AvailableForSaleSecuritiesDebtMaturitiesFairValueSubtotal	15701000000	USD
CY2017Q3	cno	Available For Sale Securities Debt Maturities Fair Value Subtotal AvailableForSaleSecuritiesDebtMaturitiesFairValueSubtotal	16960400000	USD
	cno	Available For Sale Securities Other Than Temporary Impairments Included In Accumulated Other Comprehensive Income Loss AvailableForSaleSecuritiesOtherThanTemporaryImpairmentsIncludedInAccumulatedOtherComprehensiveIncomeLoss	4700000	USD
	cno	Available For Sale Securities Value Of Securities Sold AvailableForSaleSecuritiesValueOfSecuritiesSold	290800000	USD
CY2016Q3	cno	Benefits Losses And Expenses Excluding Amortization Related To Realized Gains Losses And Fair Value Changes In Embedded Derivative Liabilities Net Of Related Amortization And Income Taxes BenefitsLossesAndExpensesExcludingAmortizationRelatedToRealizedGainsLossesAndFairValueChangesInEmbeddedDerivativeLiabilitiesNetOfRelatedAmortizationAndIncomeTaxes	893000000	USD
	cno	Benefits Losses And Expenses Excluding Amortization Related To Realized Gains Losses And Fair Value Changes In Embedded Derivative Liabilities Net Of Related Amortization And Income Taxes BenefitsLossesAndExpensesExcludingAmortizationRelatedToRealizedGainsLossesAndFairValueChangesInEmbeddedDerivativeLiabilitiesNetOfRelatedAmortizationAndIncomeTaxes	2632300000	USD
CY2017Q3	cno	Benefits Losses And Expenses Excluding Amortization Related To Realized Gains Losses And Fair Value Changes In Embedded Derivative Liabilities Net Of Related Amortization And Income Taxes BenefitsLossesAndExpensesExcludingAmortizationRelatedToRealizedGainsLossesAndFairValueChangesInEmbeddedDerivativeLiabilitiesNetOfRelatedAmortizationAndIncomeTaxes	920600000	USD
	cno	Benefits Losses And Expenses Excluding Amortization Related To Realized Gains Losses And Fair Value Changes In Embedded Derivative Liabilities Net Of Related Amortization And Income Taxes BenefitsLossesAndExpensesExcludingAmortizationRelatedToRealizedGainsLossesAndFairValueChangesInEmbeddedDerivativeLiabilitiesNetOfRelatedAmortizationAndIncomeTaxes	2784800000	USD
CY2016Q4	cno	Borrowings Related To Variable Interest Entities BorrowingsRelatedToVariableInterestEntities	1662800000	USD
CY2017Q3	cno	Borrowings Related To Variable Interest Entities BorrowingsRelatedToVariableInterestEntities	1198200000	USD
CY2016Q4	cno	Cash And Cash Equivalents Held By Variable Interest Entities CashAndCashEquivalentsHeldByVariableInterestEntities	189300000	USD
CY2017Q3	cno	Cash And Cash Equivalents Held By Variable Interest Entities CashAndCashEquivalentsHeldByVariableInterestEntities	105900000	USD
	cno	Change In Accrued Investment Income And Amortization Of Premium Or Discount On Investments ChangeInAccruedInvestmentIncomeAndAmortizationOfPremiumOrDiscountOnInvestments	-93400000	USD
	cno	Change In Accrued Investment Income And Amortization Of Premium Or Discount On Investments ChangeInAccruedInvestmentIncomeAndAmortizationOfPremiumOrDiscountOnInvestments	-233200000	USD
	cno	Change In Cash And Cash Equivalents Held By Variable Interest Entities ChangeInCashAndCashEquivalentsHeldByVariableInterestEntities	-216700000	USD
	cno	Change In Cash And Cash Equivalents Held By Variable Interest Entities ChangeInCashAndCashEquivalentsHeldByVariableInterestEntities	-83400000	USD
CY2016Q4	cno	Deferred Income Tax Assets Net Including Netof Current Income Tax Payable DeferredIncomeTaxAssetsNetIncludingNetofCurrentIncomeTaxPayable	789700000	USD
CY2017Q3	cno	Deferred Income Tax Assets Net Including Netof Current Income Tax Payable DeferredIncomeTaxAssetsNetIncludingNetofCurrentIncomeTaxPayable	567400000	USD
CY2016Q4	cno	Deferred Tax Assets Before Valuation Allowance DeferredTaxAssetsBeforeValuationAllowance	1025800000	USD
CY2017Q3	cno	Deferred Tax Assets Before Valuation Allowance DeferredTaxAssetsBeforeValuationAllowance	814800000	USD
CY2016Q3	cno	Embedded Derivative Amortization Related To Fair Value Changes In Embedded Derivative Liabilities EmbeddedDerivativeAmortizationRelatedToFairValueChangesInEmbeddedDerivativeLiabilities	2700000	USD
	cno	Embedded Derivative Amortization Related To Fair Value Changes In Embedded Derivative Liabilities EmbeddedDerivativeAmortizationRelatedToFairValueChangesInEmbeddedDerivativeLiabilities	-10400000	USD
CY2017Q3	cno	Embedded Derivative Amortization Related To Fair Value Changes In Embedded Derivative Liabilities EmbeddedDerivativeAmortizationRelatedToFairValueChangesInEmbeddedDerivativeLiabilities	600000	USD
	cno	Embedded Derivative Amortization Related To Fair Value Changes In Embedded Derivative Liabilities EmbeddedDerivativeAmortizationRelatedToFairValueChangesInEmbeddedDerivativeLiabilities	-1800000	USD
	cno	Estimated Normalized Annual Taxable Income For Current Year EstimatedNormalizedAnnualTaxableIncomeForCurrentYear	335000000	USD
	cno	Estimated Normalized Annual Taxable Income For Current Year Life Income EstimatedNormalizedAnnualTaxableIncomeForCurrentYearLifeIncome	250000000	USD
	cno	Estimated Normalized Annual Taxable Income For Current Year Nonlife Taxable Income EstimatedNormalizedAnnualTaxableIncomeForCurrentYearNonlifeTaxableIncome	85000000	USD
CY2016Q3	cno	Expenses Related To Certain Non Strategic Investments And Earnings Attributable To Non Controlling Interests ExpensesRelatedToCertainNonStrategicInvestmentsAndEarningsAttributableToNonControllingInterests	13700000	USD
	cno	Expenses Related To Certain Non Strategic Investments And Earnings Attributable To Non Controlling Interests ExpensesRelatedToCertainNonStrategicInvestmentsAndEarningsAttributableToNonControllingInterests	40500000	USD
CY2017Q3	cno	Expenses Related To Certain Non Strategic Investments And Earnings Attributable To Non Controlling Interests ExpensesRelatedToCertainNonStrategicInvestmentsAndEarningsAttributableToNonControllingInterests	17000000	USD
	cno	Expenses Related To Certain Non Strategic Investments And Earnings Attributable To Non Controlling Interests ExpensesRelatedToCertainNonStrategicInvestmentsAndEarningsAttributableToNonControllingInterests	44800000	USD
CY2016Q3	cno	Expensesrelatedtotransitionandsupportservicesagreements Expensesrelatedtotransitionandsupportservicesagreements	0	USD
	cno	Expensesrelatedtotransitionandsupportservicesagreements Expensesrelatedtotransitionandsupportservicesagreements	10000000	USD
CY2017Q3	cno	Expensesrelatedtotransitionandsupportservicesagreements Expensesrelatedtotransitionandsupportservicesagreements	0	USD
	cno	Expensesrelatedtotransitionandsupportservicesagreements Expensesrelatedtotransitionandsupportservicesagreements	0	USD
CY2016Q3	cno	Fair Value Compensation Plan Changesin Fair Value Gain Loss FairValueCompensationPlanChangesinFairValueGainLoss	6300000	USD
	cno	Fair Value Compensation Plan Changesin Fair Value Gain Loss FairValueCompensationPlanChangesinFairValueGainLoss	-12000000	USD
CY2017Q3	cno	Fair Value Compensation Plan Changesin Fair Value Gain Loss FairValueCompensationPlanChangesinFairValueGainLoss	-13400000	USD
	cno	Fair Value Compensation Plan Changesin Fair Value Gain Loss FairValueCompensationPlanChangesinFairValueGainLoss	-13400000	USD
	cno	Gain Losson Investments Excluding Cash Expenses GainLossonInvestmentsExcludingCashExpenses	52300000	USD
CY2016Q3	cno	Income Tax Expense Benefit Basedon Estimated Annual Effective Tax Rate IncomeTaxExpenseBenefitBasedonEstimatedAnnualEffectiveTaxRate	6400000	USD
	cno	Income Tax Expense Benefit Basedon Estimated Annual Effective Tax Rate IncomeTaxExpenseBenefitBasedonEstimatedAnnualEffectiveTaxRate	51200000	USD
CY2017Q3	cno	Income Tax Expense Benefit Basedon Estimated Annual Effective Tax Rate IncomeTaxExpenseBenefitBasedonEstimatedAnnualEffectiveTaxRate	41900000	USD
	cno	Income Tax Expense Benefit Basedon Estimated Annual Effective Tax Rate IncomeTaxExpenseBenefitBasedonEstimatedAnnualEffectiveTaxRate	121400000	USD
CY2016Q3	cno	Income Tax Expense Benefit Before Valuation Allowance Adjustment IncomeTaxExpenseBenefitBeforeValuationAllowanceAdjustment	16900000	USD
	cno	Income Tax Expense Benefit Before Valuation Allowance Adjustment IncomeTaxExpenseBenefitBeforeValuationAllowanceAdjustment	61700000	USD
CY2017Q3	cno	Income Tax Expense Benefit Before Valuation Allowance Adjustment IncomeTaxExpenseBenefitBeforeValuationAllowanceAdjustment	44100000	USD
	cno	Income Tax Expense Benefit Before Valuation Allowance Adjustment IncomeTaxExpenseBenefitBeforeValuationAllowanceAdjustment	123600000	USD
CY2016Q3	cno	Income Tax Expense Benefit Changein Valuation Allowanceon Discrete Items IncomeTaxExpenseBenefitChangeinValuationAllowanceonDiscreteItems	16000000	USD
	cno	Income Tax Expense Benefit Changein Valuation Allowanceon Discrete Items IncomeTaxExpenseBenefitChangeinValuationAllowanceonDiscreteItems	-11000000	USD
CY2017Q3	cno	Income Tax Expense Benefit Changein Valuation Allowanceon Discrete Items IncomeTaxExpenseBenefitChangeinValuationAllowanceonDiscreteItems	-12800000	USD
	cno	Income Tax Expense Benefit Changein Valuation Allowanceon Discrete Items IncomeTaxExpenseBenefitChangeinValuationAllowanceonDiscreteItems	-12800000	USD
CY2016Q3	cno	Income Tax Expense Benefit Current Valuation Allowance IncomeTaxExpenseBenefitCurrentValuationAllowance	10500000	USD
	cno	Income Tax Expense Benefit Current Valuation Allowance IncomeTaxExpenseBenefitCurrentValuationAllowance	10500000	USD
CY2017Q3	cno	Income Tax Expense Benefit Current Valuation Allowance IncomeTaxExpenseBenefitCurrentValuationAllowance	2200000	USD
	cno	Income Tax Expense Benefit Current Valuation Allowance IncomeTaxExpenseBenefitCurrentValuationAllowance	2200000	USD
CY2017Q3	cno	Increase To Deferred Tax Assets Due To Unrealized Gains That Would Result In Premium Deficiency If Unrealized Gains Were Realized IncreaseToDeferredTaxAssetsDueToUnrealizedGainsThatWouldResultInPremiumDeficiencyIfUnrealizedGainsWereRealized	159100000	USD
	cno	Insurance Policy Benefits InsurancePolicyBenefits	1439600000	USD
	cno	Insurance Policy Benefits InsurancePolicyBenefits	1491700000	USD
CY2016Q4	cno	Investment Borrowings InvestmentBorrowings	1647400000	USD
CY2017Q3	cno	Investment Borrowings InvestmentBorrowings	1646900000	USD
CY2016Q4	cno	Investments Held By Variable Interest Entities InvestmentsHeldByVariableInterestEntities	1724300000	USD
CY2017Q3	cno	Investments Held By Variable Interest Entities InvestmentsHeldByVariableInterestEntities	1382500000	USD
CY2017Q3	cno	Investments Held In Limited Partnerships InvestmentsHeldInLimitedPartnerships	315100000	USD
CY2017Q3	cno	Loss Limitation Based On Income Of Life Insurance Company LossLimitationBasedOnIncomeOfLifeInsuranceCompany	0.35
CY2017Q3	cno	Loss Limitation Based On Loss Of Non Life Entities LossLimitationBasedOnLossOfNonLifeEntities	0.35
	cno	Maturities And Redemptions Of Investments MaturitiesAndRedemptionsOfInvestments	1529500000	USD
	cno	Maturities And Redemptions Of Investments MaturitiesAndRedemptionsOfInvestments	2543000000	USD
CY2016Q3	cno	Net Investment Income On General Account Invested Assets NetInvestmentIncomeOnGeneralAccountInvestedAssets	301700000	USD
	cno	Net Investment Income On General Account Invested Assets NetInvestmentIncomeOnGeneralAccountInvestedAssets	888500000	USD
CY2017Q3	cno	Net Investment Income On General Account Invested Assets NetInvestmentIncomeOnGeneralAccountInvestedAssets	325900000	USD
	cno	Net Investment Income On General Account Invested Assets NetInvestmentIncomeOnGeneralAccountInvestedAssets	960300000	USD
CY2016Q3	cno	Net Investment Income On Policyholder And Reinsurer Accounts And Other Special Purpose Portfolios NetInvestmentIncomeOnPolicyholderAndReinsurerAccountsAndOtherSpecialPurposePortfolios	43100000	USD
	cno	Net Investment Income On Policyholder And Reinsurer Accounts And Other Special Purpose Portfolios NetInvestmentIncomeOnPolicyholderAndReinsurerAccountsAndOtherSpecialPurposePortfolios	82700000	USD
CY2017Q3	cno	Net Investment Income On Policyholder And Reinsurer Accounts And Other Special Purpose Portfolios NetInvestmentIncomeOnPolicyholderAndReinsurerAccountsAndOtherSpecialPurposePortfolios	52700000	USD
	cno	Net Investment Income On Policyholder And Reinsurer Accounts And Other Special Purpose Portfolios NetInvestmentIncomeOnPolicyholderAndReinsurerAccountsAndOtherSpecialPurposePortfolios	171800000	USD
	cno	Net Sales Purchases Of Trading Securities NetSalesPurchasesOfTradingSecurities	31000000	USD
	cno	Net Sales Purchases Of Trading Securities NetSalesPurchasesOfTradingSecurities	-94800000	USD
	cno	Noncash Investments Recaptured In Reinsurance Termination NoncashInvestmentsRecapturedInReinsuranceTermination	431100000	USD
	cno	Noncash Investments Recaptured In Reinsurance Termination NoncashInvestmentsRecapturedInReinsuranceTermination	0	USD
	cno	Noncredit Component Of Impairment Losses On Fixed Maturities Available For Sale NoncreditComponentOfImpairmentLossesOnFixedMaturitiesAvailableForSale	1200000	USD
	cno	Noncredit Component Of Impairment Losses On Fixed Maturities Available For Sale NoncreditComponentOfImpairmentLossesOnFixedMaturitiesAvailableForSale	2100000	USD
	cno	Noncredit Component Of Impairment Losses On Fixed Maturities Available For Sale Tax NoncreditComponentOfImpairmentLossesOnFixedMaturitiesAvailableForSaleTax	700000	USD
	cno	Noncredit Component Of Impairment Losses On Fixed Maturities Available For Sale Tax NoncreditComponentOfImpairmentLossesOnFixedMaturitiesAvailableForSaleTax	1100000	USD
	cno	Number Of Insurance Subsidiaries That Are Members Of The Federal Home Loan Bank NumberOfInsuranceSubsidiariesThatAreMembersOfTheFederalHomeLoanBank	3	subsidiary
	cno	Revenue Relatedto Transitionand Support Services Agreements RevenueRelatedtoTransitionandSupportServicesAgreements	0	USD
CY2016Q4	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	239600000	USD
CY2016Q3	cno	Other Comprehensive Income Loss Amortizationof Present Valueof Future Profitsand Deferred Acquisition Costs Unrealized Holding Gain Loss Arising During Periodbefore Tax OtherComprehensiveIncomeLossAmortizationofPresentValueofFutureProfitsandDeferredAcquisitionCostsUnrealizedHoldingGainLossArisingDuringPeriodbeforeTax	11300000	USD
	cno	Other Comprehensive Income Loss Amortizationof Present Valueof Future Profitsand Deferred Acquisition Costs Unrealized Holding Gain Loss Arising During Periodbefore Tax OtherComprehensiveIncomeLossAmortizationofPresentValueofFutureProfitsandDeferredAcquisitionCostsUnrealizedHoldingGainLossArisingDuringPeriodbeforeTax	119600000	USD
CY2017Q3	cno	Other Comprehensive Income Loss Amortizationof Present Valueof Future Profitsand Deferred Acquisition Costs Unrealized Holding Gain Loss Arising During Periodbefore Tax OtherComprehensiveIncomeLossAmortizationofPresentValueofFutureProfitsandDeferredAcquisitionCostsUnrealizedHoldingGainLossArisingDuringPeriodbeforeTax	1800000	USD
	cno	Other Comprehensive Income Loss Amortizationof Present Valueof Future Profitsand Deferred Acquisition Costs Unrealized Holding Gain Loss Arising During Periodbefore Tax OtherComprehensiveIncomeLossAmortizationofPresentValueofFutureProfitsandDeferredAcquisitionCostsUnrealizedHoldingGainLossArisingDuringPeriodbeforeTax	25300000	USD
CY2016Q3	cno	Other Comprehensive Income Loss Amortizationof Present Valueof Future Profitsand Deferred Acquisitions Costs Reductionin Premium Deficienciesbefore Tax OtherComprehensiveIncomeLossAmortizationofPresentValueofFutureProfitsandDeferredAcquisitionsCostsReductioninPremiumDeficienciesbeforeTax	-82800000	USD
	cno	Other Comprehensive Income Loss Amortizationof Present Valueof Future Profitsand Deferred Acquisitions Costs Reductionin Premium Deficienciesbefore Tax OtherComprehensiveIncomeLossAmortizationofPresentValueofFutureProfitsandDeferredAcquisitionsCostsReductioninPremiumDeficienciesbeforeTax	-493400000	USD
CY2017Q3	cno	Other Comprehensive Income Loss Amortizationof Present Valueof Future Profitsand Deferred Acquisitions Costs Reductionin Premium Deficienciesbefore Tax OtherComprehensiveIncomeLossAmortizationofPresentValueofFutureProfitsandDeferredAcquisitionsCostsReductioninPremiumDeficienciesbeforeTax	-31000000	USD
	cno	Other Comprehensive Income Loss Amortizationof Present Valueof Future Profitsand Deferred Acquisitions Costs Reductionin Premium Deficienciesbefore Tax OtherComprehensiveIncomeLossAmortizationofPresentValueofFutureProfitsandDeferredAcquisitionsCostsReductioninPremiumDeficienciesbeforeTax	-243000000	USD
CY2016Q3	cno	Other Comprehensive Income Loss Reclassification Adjustment For Amortization Of Present Value Of Future Profits And Deferred Acquisition Costs Related To Net Realized Investment Gains Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentForAmortizationOfPresentValueOfFutureProfitsAndDeferredAcquisitionCostsRelatedToNetRealizedInvestmentGainsBeforeTax	200000	USD
	cno	Other Comprehensive Income Loss Reclassification Adjustment For Amortization Of Present Value Of Future Profits And Deferred Acquisition Costs Related To Net Realized Investment Gains Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentForAmortizationOfPresentValueOfFutureProfitsAndDeferredAcquisitionCostsRelatedToNetRealizedInvestmentGainsBeforeTax	900000	USD
CY2017Q3	cno	Other Comprehensive Income Loss Reclassification Adjustment For Amortization Of Present Value Of Future Profits And Deferred Acquisition Costs Related To Net Realized Investment Gains Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentForAmortizationOfPresentValueOfFutureProfitsAndDeferredAcquisitionCostsRelatedToNetRealizedInvestmentGainsBeforeTax	700000	USD
	cno	Other Comprehensive Income Loss Reclassification Adjustment For Amortization Of Present Value Of Future Profits And Deferred Acquisition Costs Related To Net Realized Investment Gains Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentForAmortizationOfPresentValueOfFutureProfitsAndDeferredAcquisitionCostsRelatedToNetRealizedInvestmentGainsBeforeTax	1000000	USD
CY2016Q3	cno	Other Comprehensive Income Loss Unrealized Holding Gain Loss On Securities Arising During Period Net Of Reclassification And Amortization Adjustments Before Tax OtherComprehensiveIncomeLossUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfReclassificationAndAmortizationAdjustmentsBeforeTax	119800000	USD
	cno	Other Comprehensive Income Loss Unrealized Holding Gain Loss On Securities Arising During Period Net Of Reclassification And Amortization Adjustments Before Tax OtherComprehensiveIncomeLossUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfReclassificationAndAmortizationAdjustmentsBeforeTax	692900000	USD
CY2017Q3	cno	Other Comprehensive Income Loss Unrealized Holding Gain Loss On Securities Arising During Period Net Of Reclassification And Amortization Adjustments Before Tax OtherComprehensiveIncomeLossUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfReclassificationAndAmortizationAdjustmentsBeforeTax	61100000	USD
	cno	Other Comprehensive Income Loss Unrealized Holding Gain Loss On Securities Arising During Period Net Of Reclassification And Amortization Adjustments Before Tax OtherComprehensiveIncomeLossUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfReclassificationAndAmortizationAdjustmentsBeforeTax	483200000	USD
	cno	Other Than Temporary Impairment Losses Losseson Other Investments Following Unforeseen Events OtherThanTemporaryImpairmentLossesLossesonOtherInvestmentsFollowingUnforeseenEvents	900000	USD
	cno	Other Than Temporary Impairment Losses Losseson Other Investments Following Unforeseen Events OtherThanTemporaryImpairmentLossesLossesonOtherInvestmentsFollowingUnforeseenEvents	7300000	USD
CY2017Q3	cno	Ownership Change Threshold Restricting Net Operating Loss Usage OwnershipChangeThresholdRestrictingNetOperatingLossUsage	0.5
CY2016Q4	cno	Persistency Bonus Benefits Included In Insurance Liabilities PersistencyBonusBenefitsIncludedInInsuranceLiabilities	500000	USD
CY2017Q3	cno	Persistency Bonus Benefits Included In Insurance Liabilities PersistencyBonusBenefitsIncludedInInsuranceLiabilities	400000	USD
	cno	Policy Acquisition Costs PolicyAcquisitionCosts	179400000	USD
	cno	Policy Acquisition Costs PolicyAcquisitionCosts	183400000	USD
CY2016Q4	cno	Prepaid Accrued Income Taxes Current PrepaidAccruedIncomeTaxesCurrent	4100000	USD
CY2017Q3	cno	Prepaid Accrued Income Taxes Current PrepaidAccruedIncomeTaxesCurrent	-6500000	USD
CY2016Q3	cno	Pretaxoperatingearnings Pretaxoperatingearnings	98300000	USD
	cno	Pretaxoperatingearnings Pretaxoperatingearnings	275300000	USD
CY2017Q3	cno	Pretaxoperatingearnings Pretaxoperatingearnings	115800000	USD
	cno	Pretaxoperatingearnings Pretaxoperatingearnings	329800000	USD
	cno	Proceeds From Investment Borrowings Related To Variable Interest Entities ProceedsFromInvestmentBorrowingsRelatedToVariableInterestEntities	477100000	USD
	cno	Proceeds From Investment Borrowings Related To Variable Interest Entities ProceedsFromInvestmentBorrowingsRelatedToVariableInterestEntities	387300000	USD
	cno	Proceeds Upon Recaptureof Reinsurance ProceedsUponRecaptureofReinsurance	73600000	USD
	cno	Proceeds Upon Recaptureof Reinsurance ProceedsUponRecaptureofReinsurance	0	USD
	cno	Purchases Of Investments PurchasesOfInvestments	4196700000	USD
	cno	Purchases Of Investments PurchasesOfInvestments	4076800000	USD
CY2017Q3	cno	Reduction To Deferred Acquisition Costs Due To Unrealized Gains That Would Result In Premium Deficiency If Unrealized Gains Were Realized ReductionToDeferredAcquisitionCostsDueToUnrealizedGainsThatWouldResultInPremiumDeficiencyIfUnrealizedGainsWereRealized	135800000	USD
CY2017Q3	cno	Reduction To Present Value Of Future Profits Due To Unrealized Gains That Would Result In Premium Deficiency If Unrealized Gains Were Realized ReductionToPresentValueOfFutureProfitsDueToUnrealizedGainsThatWouldResultInPremiumDeficiencyIfUnrealizedGainsWereRealized	86700000	USD
CY2016Q3	cno	Reinsurance Gain Loss On Recapture ReinsuranceGainLossOnRecapture	-75400000	USD
	cno	Reinsurance Gain Loss On Recapture ReinsuranceGainLossOnRecapture	-75400000	USD
CY2017Q3	cno	Reinsurance Gain Loss On Recapture ReinsuranceGainLossOnRecapture	0	USD
	cno	Reinsurance Gain Loss On Recapture ReinsuranceGainLossOnRecapture	0	USD
	cno	Repayments Of Investment Borrowings Related To Variable Interest Entities RepaymentsOfInvestmentBorrowingsRelatedToVariableInterestEntities	470600000	USD
	cno	Repayments Of Investment Borrowings Related To Variable Interest Entities RepaymentsOfInvestmentBorrowingsRelatedToVariableInterestEntities	862300000	USD
CY2016Q3	cno	Revenue Relatedto Transitionand Support Services Agreements RevenueRelatedtoTransitionandSupportServicesAgreements	0	USD
	cno	Revenue Relatedto Transitionand Support Services Agreements RevenueRelatedtoTransitionandSupportServicesAgreements	10000000	USD
CY2017Q3	cno	Revenue Relatedto Transitionand Support Services Agreements RevenueRelatedtoTransitionandSupportServicesAgreements	0	USD
CY2016Q3	cno	Revenues Excluding Realized Gains Losses RevenuesExcludingRealizedGainsLosses	991300000	USD
	cno	Revenues Excluding Realized Gains Losses RevenuesExcludingRealizedGainsLosses	2907600000	USD
CY2017Q3	cno	Revenues Excluding Realized Gains Losses RevenuesExcludingRealizedGainsLosses	1036400000	USD
	cno	Revenues Excluding Realized Gains Losses RevenuesExcludingRealizedGainsLosses	3114600000	USD
CY2016Q3	cno	Revenues Related To Certain Non Strategic Investments And Earnings Attributable To Non Controlling Interests RevenuesRelatedToCertainNonStrategicInvestmentsAndEarningsAttributableToNonControllingInterests	13000000	USD
	cno	Revenues Related To Certain Non Strategic Investments And Earnings Attributable To Non Controlling Interests RevenuesRelatedToCertainNonStrategicInvestmentsAndEarningsAttributableToNonControllingInterests	39300000	USD
CY2017Q3	cno	Revenues Related To Certain Non Strategic Investments And Earnings Attributable To Non Controlling Interests RevenuesRelatedToCertainNonStrategicInvestmentsAndEarningsAttributableToNonControllingInterests	13700000	USD
	cno	Revenues Related To Certain Non Strategic Investments And Earnings Attributable To Non Controlling Interests RevenuesRelatedToCertainNonStrategicInvestmentsAndEarningsAttributableToNonControllingInterests	40200000	USD
	cno	Sales Of Investments SalesOfInvestments	2225700000	USD
	cno	Sales Of Investments SalesOfInvestments	1742500000	USD
	cno	Share Based Compensation Noncash Portion ShareBasedCompensationNoncashPortion	18900000	USD
	cno	Share Based Compensation Noncash Portion ShareBasedCompensationNoncashPortion	17800000	USD
	cno	Stock Based Compensation StockBasedCompensation	22400000	USD
	cno	Stock Based Compensation StockBasedCompensation	21600000	USD
CY2017Q2	cno	Stock Repurchase Program Increase In Authorized Amount StockRepurchaseProgramIncreaseInAuthorizedAmount	300000000	USD
CY2017Q3	cno	Stock Repurchase Program Remaining Repurchase Authorized Amount StockRepurchaseProgramRemainingRepurchaseAuthorizedAmount	412600000	USD
	cno	Total Other Than Temporary Impairment Losses On Investments Held By Variable Interest Entities TotalOtherThanTemporaryImpairmentLossesOnInvestmentsHeldByVariableInterestEntities	1200000	USD
	cno	Total Other Than Temporary Impairment Losses On Investments Held By Variable Interest Entities TotalOtherThanTemporaryImpairmentLossesOnInvestmentsHeldByVariableInterestEntities	400000	USD
CY2017Q3	cno	Unfunded Commitmentsto Limited Partnerships UnfundedCommitmentstoLimitedPartnerships	266200000	USD
	cno	Valuation Allowance Deferred Tax Asset Valuation Model Forecast Periodof Model ValuationAllowanceDeferredTaxAssetValuationModelForecastPeriodofModel	P5Y
	cno	Variable Interest Entities Investments Sold VariableInterestEntitiesInvestmentsSold	186600000	USD
	cno	Variable Interest Entities Investments Sold VariableInterestEntitiesInvestmentsSold	86000000	USD
	cno	Variable Interest Entities Net Gain Loss From Sale Of Fixed Maturity Investments VariableInterestEntitiesNetGainLossFromSaleOfFixedMaturityInvestments	-12100000	USD
	cno	Variable Interest Entities Net Gain Loss From Sale Of Fixed Maturity Investments VariableInterestEntitiesNetGainLossFromSaleOfFixedMaturityInvestments	2200000	USD
	cno	Variable Interest Entities Net Realized Gain Loss On Investments VariableInterestEntitiesNetRealizedGainLossOnInvestments	-20600000	USD
	cno	Variable Interest Entities Net Realized Gain Loss On Investments VariableInterestEntitiesNetRealizedGainLossOnInvestments	-2500000	USD
CY2017Q3	cno	Variable Interest Entity Amortized Cost Securities Held VariableInterestEntityAmortizedCostSecuritiesHeld	1381700000	USD
CY2017Q3	cno	Variable Interest Entity Fixed Maturity Securities Fair Value VariableInterestEntityFixedMaturitySecuritiesFairValue	1382500000	USD
CY2016Q3	cno	Variable Interest Entity Gain Losson Dissolution VariableInterestEntityGainLossonDissolution	0	USD
	cno	Variable Interest Entity Gain Losson Dissolution VariableInterestEntityGainLossonDissolution	-7300000	USD
CY2017Q3	cno	Variable Interest Entity Gain Losson Dissolution VariableInterestEntityGainLossonDissolution	-600000	USD
	cno	Variable Interest Entity Gain Losson Dissolution VariableInterestEntityGainLossonDissolution	-4300000	USD
CY2017Q3	cno	Variable Interest Entity Gross Unrealized Gains Fixed Maturity Securities VariableInterestEntityGrossUnrealizedGainsFixedMaturitySecurities	8400000	USD
CY2017Q3	cno	Variable Interest Entity Gross Unrealized Losses Fixed Maturity Securities VariableInterestEntityGrossUnrealizedLossesFixedMaturitySecurities	7600000	USD
	cno	Variable Interest Entity Investments Gross Investment Losses From Sale Before Tax VariableInterestEntityInvestmentsGrossInvestmentLossesFromSaleBeforeTax	20300000	USD
	cno	Variable Interest Entity Investments Gross Investment Losses From Sale Before Tax VariableInterestEntityInvestmentsGrossInvestmentLossesFromSaleBeforeTax	2000000	USD
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
	dei	Document Period End Date DocumentPeriodEndDate	2017-09-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001224608
CY2017Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	167762323	shares
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	CNO Financial Group, Inc.
CY2017Q3	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	268000000	USD
CY2016Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	622400000	USD
CY2017Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	933600000	USD
CY2016Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	3212100000	USD
CY2017Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	3094500000	USD
CY2017Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	3213000000	USD
CY2016Q3	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	64700000	USD
	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	181600000	USD
CY2017Q3	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	58200000	USD
	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	181300000	USD
CY2016Q4	us-gaap	Assets Assets	31975200000	USD
CY2017Q3	us-gaap	Assets Assets	32704600000	USD
CY2017Q1	us-gaap	Assets Assets	31975500000	USD
CY2016Q3	us-gaap	Assumed Premiums Written AssumedPremiumsWritten	8300000	USD
	us-gaap	Assumed Premiums Written AssumedPremiumsWritten	25800000	USD
CY2017Q3	us-gaap	Assumed Premiums Written AssumedPremiumsWritten	7400000	USD
	us-gaap	Assumed Premiums Written AssumedPremiumsWritten	23100000	USD
CY2016Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	19803100000	USD
CY2017Q3	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	20092500000	USD
CY2016Q4	us-gaap	Available For Sale Equity Securities Amortized Cost Basis AvailableForSaleEquitySecuritiesAmortizedCostBasis	580700000	USD
CY2017Q3	us-gaap	Available For Sale Equity Securities Amortized Cost Basis AvailableForSaleEquitySecuritiesAmortizedCostBasis	688700000	USD
CY2016Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	84800000	USD
CY2017Q3	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	36200000	USD
CY2016Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss	194300000	USD
CY2017Q3	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss	47800000	USD
CY2016Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue	4500600000	USD
CY2017Q3	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue	2065900000	USD
CY2016Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	109500000	USD
CY2017Q3	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	11600000	USD
CY2016Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	3440800000	USD
CY2017Q3	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	1332500000	USD
CY2016Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	1059800000	USD
CY2017Q3	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	733400000	USD
CY2016Q4	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	1549100000	USD
CY2017Q3	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	1562800000	USD
CY2016Q4	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	1620800000	USD
CY2017Q3	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	1671100000	USD
CY2016Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	2243800000	USD
CY2017Q3	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	2004800000	USD
CY2016Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	2399500000	USD
CY2017Q3	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	2131700000	USD
CY2016Q4	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	10395000000	USD
CY2017Q3	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	11240400000	USD
CY2016Q4	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	11320900000	USD
CY2017Q3	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	12751500000	USD
CY2016Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	354700000	USD
CY2017Q3	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	398100000	USD
CY2016Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	359800000	USD
CY2017Q3	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	406100000	USD
CY2016Q4	us-gaap	Available For Sale Securities Debt Maturities Without Single Maturity Date Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost	5260500000	USD
CY2017Q3	us-gaap	Available For Sale Securities Debt Maturities Without Single Maturity Date Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost	4886400000	USD
CY2016Q4	us-gaap	Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue	5395200000	USD
CY2017Q3	us-gaap	Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue	5169500000	USD
CY2016Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	21096200000	USD
CY2017Q3	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	22129900000	USD
CY2016Q4	us-gaap	Available For Sale Securities Equity Securities AvailableForSaleSecuritiesEquitySecurities	584200000	USD
CY2017Q3	us-gaap	Available For Sale Securities Equity Securities AvailableForSaleSecuritiesEquitySecurities	713300000	USD
CY2016Q3	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	966600000	USD
	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	2807700000	USD
CY2017Q3	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	949400000	USD
	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	2852000000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	432300000	USD
CY2016Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	706000000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	478900000	USD
CY2017Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	765900000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	273700000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	287000000	USD
CY2016Q3	us-gaap	Ceded Premiums Written CededPremiumsWritten	32200000	USD
	us-gaap	Ceded Premiums Written CededPremiumsWritten	97300000	USD
CY2017Q3	us-gaap	Ceded Premiums Written CededPremiumsWritten	27100000	USD
	us-gaap	Ceded Premiums Written CededPremiumsWritten	79900000	USD
CY2016Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.08
	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.09
	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.26
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2017Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	8000000000	shares
CY2017Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	8000000000	shares
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	173753614	shares
CY2017Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	167762323	shares
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	173753614	shares
CY2017Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	167762323	shares
CY2016Q4	us-gaap	Common Stock Value CommonStockValue	1700000	USD
CY2017Q3	us-gaap	Common Stock Value CommonStockValue	1700000	USD
CY2016Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	96300000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	576700000	USD
CY2017Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	139900000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	557700000	USD
CY2016Q4	us-gaap	Cumulative Effect Of New Accounting Principle In Period Of Adoption CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	300000	USD
CY2016Q3	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	46800000	USD
CY2016Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	51600000	USD
CY2017Q3	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	25900000	USD
	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	68500000	USD
CY2016Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	912900000	USD
CY2017Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	914400000	USD
CY2016Q4	us-gaap	Deferred Finance Costs Noncurrent Gross DeferredFinanceCostsNoncurrentGross	12100000	USD
CY2017Q3	us-gaap	Deferred Finance Costs Noncurrent Gross DeferredFinanceCostsNoncurrentGross	10600000	USD
CY2016Q3	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-29900000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	10100000	USD
CY2017Q3	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	18200000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	55100000	USD
CY2016Q3	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	13800000	USD
	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	-13200000	USD
CY2017Q3	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	-15000000	USD
	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	-15000000	USD
CY2016Q4	us-gaap	Deferred Policy Acquisition Costs DeferredPolicyAcquisitionCosts	1044700000	USD
CY2017Q3	us-gaap	Deferred Policy Acquisition Costs DeferredPolicyAcquisitionCosts	1023800000	USD
	us-gaap	Deferred Sales Inducements Additions DeferredSalesInducementsAdditions	2800000	USD
	us-gaap	Deferred Sales Inducements Additions DeferredSalesInducementsAdditions	1500000	USD
	us-gaap	Deferred Sales Inducements Amortization Expense DeferredSalesInducementsAmortizationExpense	7100000	USD
	us-gaap	Deferred Sales Inducements Amortization Expense DeferredSalesInducementsAmortizationExpense	6600000	USD
CY2016Q4	us-gaap	Deferred Sales Inducements Net DeferredSalesInducementsNet	49400000	USD
CY2017Q3	us-gaap	Deferred Sales Inducements Net DeferredSalesInducementsNet	44300000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	1647700000	USD
CY2017Q3	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	1606700000	USD
CY2017Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	1045900000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Investments DeferredTaxAssetsInvestments	17800000	USD
CY2017Q3	us-gaap	Deferred Tax Assets Investments DeferredTaxAssetsInvestments	13700000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	785600000	USD
CY2017Q3	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	573900000	USD
CY2017Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	790000000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	882900000	USD
CY2017Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	841800000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	12300000	USD
CY2017Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	12200000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	66300000	USD
CY2017Q3	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	60100000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Policyholder Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsPolicyholderLiabilities	668400000	USD
CY2017Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Policyholder Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsPolicyholderLiabilities	678900000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	240200000	USD
CY2017Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	240900000	USD
CY2017Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	255900000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	621900000	USD
CY2017Q3	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	791900000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Deferred Policy Acquisition Cost DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost	277800000	USD
CY2017Q3	us-gaap	Deferred Tax Liabilities Deferred Expense Deferred Policy Acquisition Cost DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost	275000000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Other Comprehensive Income DeferredTaxLiabilitiesOtherComprehensiveIncome	344100000	USD
CY2017Q3	us-gaap	Deferred Tax Liabilities Other Comprehensive Income DeferredTaxLiabilitiesOtherComprehensiveIncome	516900000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	199100000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	200800000	USD
CY2016Q3	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	35400000	USD
	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	-16800000	USD
CY2017Q3	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	30900000	USD
	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	97800000	USD
	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	40800000	USD
	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	44700000	USD
CY2016Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.11
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.70
CY2017Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.60
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.44
CY2016Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.11
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.69
CY2017Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.59
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.43
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.297
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.342
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35
	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.061
	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.006
	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.010
	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.015
	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.018
	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.013
CY2016Q3	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet	12100000	USD
	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet	-47000000	USD
CY2017Q3	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet	2900000	USD
	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet	-9800000	USD
CY2016Q3	us-gaap	Fees And Commissions FeesAndCommissions	10500000	USD
	us-gaap	Fees And Commissions FeesAndCommissions	38700000	USD
CY2017Q3	us-gaap	Fees And Commissions FeesAndCommissions	12200000	USD
	us-gaap	Fees And Commissions FeesAndCommissions	35500000	USD
CY2016Q3	us-gaap	Gain Loss On Investments GainLossOnInvestments	11600000	USD
	us-gaap	Gain Loss On Investments GainLossOnInvestments	23300000	USD
CY2017Q3	us-gaap	Gain Loss On Investments GainLossOnInvestments	29200000	USD
	us-gaap	Gain Loss On Investments GainLossOnInvestments	52300000	USD
CY2016Q3	us-gaap	Gain Loss On Investments Excluding Other Than Temporary Impairments GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments	12800000	USD
	us-gaap	Gain Loss On Investments Excluding Other Than Temporary Impairments GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments	55400000	USD
CY2017Q3	us-gaap	Gain Loss On Investments Excluding Other Than Temporary Impairments GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments	34500000	USD
	us-gaap	Gain Loss On Investments Excluding Other Than Temporary Impairments GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments	74800000	USD
CY2017Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	0	USD
CY2017Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	0	USD
CY2017Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	0	USD
CY2017Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	325000000	USD
CY2017Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-5500000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-5500000	USD
CY2016Q3	us-gaap	Impairment Of Investments ImpairmentOfInvestments	1200000	USD
	us-gaap	Impairment Of Investments ImpairmentOfInvestments	24800000	USD
CY2017Q3	us-gaap	Impairment Of Investments ImpairmentOfInvestments	4700000	USD
	us-gaap	Impairment Of Investments ImpairmentOfInvestments	17300000	USD
CY2016Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	49300000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	172500000	USD
CY2017Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	129900000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	355100000	USD
CY2016Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	30700000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	48500000	USD
CY2017Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	29100000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	108600000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	5500000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	58000000	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	43000000	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	50600000	USD
	us-gaap	Increase Decrease In Deferred Policy Acquisition Costs IncreaseDecreaseInDeferredPolicyAcquisitionCosts	179400000	USD
	us-gaap	Increase Decrease In Deferred Policy Acquisition Costs IncreaseDecreaseInDeferredPolicyAcquisitionCosts	183400000	USD
	us-gaap	Increase Decrease In Insurance Liabilities IncreaseDecreaseInInsuranceLiabilities	310200000	USD
	us-gaap	Increase Decrease In Insurance Liabilities IncreaseDecreaseInInsuranceLiabilities	321500000	USD
CY2016Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1476000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1733000	shares
CY2017Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2298000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1910000	shares
CY2016Q3	us-gaap	Interest Expense InterestExpense	29400000	USD
	us-gaap	Interest Expense InterestExpense	86000000	USD
CY2017Q3	us-gaap	Interest Expense InterestExpense	30100000	USD
	us-gaap	Interest Expense InterestExpense	92300000	USD
	us-gaap	Interest Paid InterestPaid	66500000	USD
	us-gaap	Interest Paid InterestPaid	81000000	USD
CY2016Q4	us-gaap	Investments Investments	26237600000	USD
CY2017Q3	us-gaap	Investments Investments	27054600000	USD
CY2016Q4	us-gaap	Liabilities Liabilities	27488300000	USD
CY2017Q3	us-gaap	Liabilities Liabilities	27822900000	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	31975200000	USD
CY2017Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	32704600000	USD
CY2017Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	31975500000	USD
CY2016Q4	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	500600000	USD
CY2017Q3	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	519500000	USD
CY2016Q4	us-gaap	Liability For Future Policy Benefits LiabilityForFuturePolicyBenefits	10953300000	USD
CY2017Q3	us-gaap	Liability For Future Policy Benefits LiabilityForFuturePolicyBenefits	11374100000	USD
CY2017Q3	us-gaap	Long Term Debt LongTermDebt	925000000	USD
CY2017Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	500000000	USD
CY2017Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	100000000	USD
CY2016Q4	us-gaap	Mortgage Loans On Real Estate MortgageLoansOnRealEstate	1768000000	USD
CY2017Q3	us-gaap	Mortgage Loans On Real Estate MortgageLoansOnRealEstate	1667800000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-37500000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-510000000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-273600000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	363300000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	584800000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	433700000	USD
CY2016Q3	us-gaap	Net Income Loss NetIncomeLoss	18600000	USD
	us-gaap	Net Income Loss NetIncomeLoss	124000000	USD
CY2017Q3	us-gaap	Net Income Loss NetIncomeLoss	100800000	USD
	us-gaap	Net Income Loss NetIncomeLoss	246500000	USD
CY2016Q4	us-gaap	Notes Payable NotesPayable	912900000	USD
CY2017Q3	us-gaap	Notes Payable NotesPayable	914400000	USD
CY2017Q3	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	2405100000	USD
CY2016Q4	us-gaap	Other Assets OtherAssets	328500000	USD
CY2017Q3	us-gaap	Other Assets OtherAssets	350200000	USD
CY2016Q3	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	119800000	USD
	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	701500000	USD
CY2017Q3	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	61100000	USD
	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	483200000	USD
CY2016Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	77700000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	452700000	USD
CY2017Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	39100000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	311200000	USD
CY2016Q3	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax	0	USD
	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax	-8600000	USD
CY2017Q3	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax	0	USD
	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax	0	USD
CY2016Q3	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	14600000	USD
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	24200000	USD
CY2017Q3	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	27700000	USD
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	44000000	USD
CY2016Q3	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	42100000	USD
	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	248800000	USD
CY2017Q3	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	22000000	USD
	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	172000000	USD
CY2016Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	228300000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	1329200000	USD
CY2017Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	120900000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	794500000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	451500000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	309100000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	248100000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	170900000	USD
CY2016Q3	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	187300000	USD
	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	603500000	USD
CY2017Q3	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	217500000	USD
	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	631300000	USD
CY2016Q4	us-gaap	Other Investments OtherInvestments	589500000	USD
CY2017Q3	us-gaap	Other Investments OtherInvestments	752100000	USD
CY2016Q4	us-gaap	Other Liabilities OtherLiabilities	611400000	USD
CY2017Q3	us-gaap	Other Liabilities OtherLiabilities	789100000	USD
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	55600000	USD
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	77700000	USD
CY2016Q3	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	8300000	USD
	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	8300000	USD
CY2017Q3	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	0	USD
	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	0	USD
CY2016Q3	us-gaap	Other Than Temporary Impairment Losses Investments Portion In Other Comprehensive Income Loss Before Tax Including Portion Attributable To Noncontrolling Interest Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossBeforeTaxIncludingPortionAttributableToNoncontrollingInterestAvailableforsaleSecurities	0	USD
	us-gaap	Other Than Temporary Impairment Losses Investments Portion In Other Comprehensive Income Loss Before Tax Including Portion Attributable To Noncontrolling Interest Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossBeforeTaxIncludingPortionAttributableToNoncontrollingInterestAvailableforsaleSecurities	0	USD
CY2017Q3	us-gaap	Other Than Temporary Impairment Losses Investments Portion In Other Comprehensive Income Loss Before Tax Including Portion Attributable To Noncontrolling Interest Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossBeforeTaxIncludingPortionAttributableToNoncontrollingInterestAvailableforsaleSecurities	0	USD
	us-gaap	Other Than Temporary Impairment Losses Investments Portion In Other Comprehensive Income Loss Before Tax Including Portion Attributable To Noncontrolling Interest Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossBeforeTaxIncludingPortionAttributableToNoncontrollingInterestAvailableforsaleSecurities	-900000	USD
CY2016Q3	us-gaap	Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet	1200000	USD
	us-gaap	Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet	24800000	USD
CY2017Q3	us-gaap	Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet	4700000	USD
	us-gaap	Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet	18200000	USD
	us-gaap	Payments For Other Operating Activities PaymentsForOtherOperatingActivities	552100000	USD
	us-gaap	Payments For Other Operating Activities PaymentsForOtherOperatingActivities	546000000	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	17800000	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	23600000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	210000000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	142300000	USD
	us-gaap	Payments Of Dividends PaymentsOfDividends	40900000	USD
	us-gaap	Payments Of Dividends PaymentsOfDividends	44500000	USD
CY2016Q4	us-gaap	Policy Loans Receivable PolicyLoansReceivable	112000000	USD
CY2017Q3	us-gaap	Policy Loans Receivable PolicyLoansReceivable	114600000	USD
CY2016Q3	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	609800000	USD
	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	1861200000	USD
CY2017Q3	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	638100000	USD
	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	1941600000	USD
CY2016Q4	us-gaap	Policyholder Funds PolicyholderFunds	10912700000	USD
CY2017Q3	us-gaap	Policyholder Funds PolicyholderFunds	11113500000	USD
CY2016Q3	us-gaap	Premiums Earned Net PremiumsEarnedNet	649000000	USD
	us-gaap	Premiums Earned Net PremiumsEarnedNet	1947000000	USD
CY2017Q3	us-gaap	Premiums Earned Net PremiumsEarnedNet	659300000	USD
	us-gaap	Premiums Earned Net PremiumsEarnedNet	1987200000	USD
	us-gaap	Proceeds From Annuities And Investment Certificates ProceedsFromAnnuitiesAndInvestmentCertificates	992100000	USD
	us-gaap	Proceeds From Annuities And Investment Certificates ProceedsFromAnnuitiesAndInvestmentCertificates	1067200000	USD
	us-gaap	Proceeds From Federal Home Loan Bank Borrowings ProceedsFromFederalHomeLoanBankBorrowings	432700000	USD
	us-gaap	Proceeds From Federal Home Loan Bank Borrowings ProceedsFromFederalHomeLoanBankBorrowings	332000000	USD
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	172800000	shares
CY2016Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	174247000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	177640000	shares
CY2017Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	168684000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	170890000	shares
CY2016Q4	us-gaap	Value Of Business Acquired Voba ValueOfBusinessAcquiredVOBA	401800000	USD
CY2017Q3	us-gaap	Value Of Business Acquired Voba ValueOfBusinessAcquiredVOBA	368500000	USD
CY2016Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	175723000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	179373000	shares
CY2017Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	170982000	shares
	us-gaap	Proceeds From Fees Received ProceedsFromFeesReceived	38700000	USD
	us-gaap	Proceeds From Fees Received ProceedsFromFeesReceived	35500000	USD
	us-gaap	Proceeds From Insurance Premiums Collected ProceedsFromInsurancePremiumsCollected	1837900000	USD
	us-gaap	Proceeds From Insurance Premiums Collected ProceedsFromInsurancePremiumsCollected	1859400000	USD
	us-gaap	Proceeds From Interest And Dividends Received ProceedsFromInterestAndDividendsReceived	877700000	USD
	us-gaap	Proceeds From Interest And Dividends Received ProceedsFromInterestAndDividendsReceived	898900000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	6900000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	6000000	USD
CY2016Q3	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	11600000	USD
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	23300000	USD
CY2017Q3	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	29200000	USD
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	52300000	USD
CY2016Q3	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Ceded ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded	31700000	USD
	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Ceded ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded	113300000	USD
CY2017Q3	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Ceded ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded	22600000	USD
	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Ceded ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded	69100000	USD
CY2016Q4	us-gaap	Reinsurance Recoverables On Paid Losses ReinsuranceRecoverablesOnPaidLosses	2260400000	USD
CY2017Q3	us-gaap	Reinsurance Recoverables On Paid Losses ReinsuranceRecoverablesOnPaidLosses	2195500000	USD
	us-gaap	Repayments Of Annuities And Investment Certificates RepaymentsOfAnnuitiesAndInvestmentCertificates	891500000	USD
	us-gaap	Repayments Of Annuities And Investment Certificates RepaymentsOfAnnuitiesAndInvestmentCertificates	920800000	USD
	us-gaap	Repayments Of Federal Home Loan Bank Borrowings RepaymentsOfFederalHomeLoanBankBorrowings	333300000	USD
	us-gaap	Repayments Of Federal Home Loan Bank Borrowings RepaymentsOfFederalHomeLoanBankBorrowings	332600000	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	650700000	USD
CY2017Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	851900000	USD
CY2017Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	650100000	USD
CY2016Q3	us-gaap	Revenues Revenues	1015900000	USD
	us-gaap	Revenues Revenues	2980200000	USD
CY2017Q3	us-gaap	Revenues Revenues	1079300000	USD
	us-gaap	Revenues Revenues	3207100000	USD
CY2016Q4	us-gaap	Separate Account Assets SeparateAccountAssets	4700000	USD
CY2017Q3	us-gaap	Separate Account Assets SeparateAccountAssets	4800000	USD
CY2016Q4	us-gaap	Separate Accounts Liability SeparateAccountsLiability	4700000	USD
CY2017Q3	us-gaap	Separate Accounts Liability SeparateAccountsLiability	4800000	USD
	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	103000	shares
	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	203000000	USD
	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	140100000	USD
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	4138500000	USD
CY2016Q3	us-gaap	Stockholders Equity StockholdersEquity	4493800000	USD
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	4486900000	USD
CY2017Q3	us-gaap	Stockholders Equity StockholdersEquity	4881700000	USD
CY2017Q1	us-gaap	Stockholders Equity StockholdersEquity	4487200000	USD
CY2016Q4	us-gaap	Trading Securities TradingSecurities	363400000	USD
CY2017Q3	us-gaap	Trading Securities TradingSecurities	294400000	USD
CY2016Q4	us-gaap	Unearned Premiums UnearnedPremiums	282500000	USD
CY2017Q3	us-gaap	Unearned Premiums UnearnedPremiums	262400000	USD
	us-gaap	Loss Contingency Disclosures LossContingencyDisclosures	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">LITIGATION AND OTHER LEGAL PROCEEDINGS</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Legal Proceedings</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company and its subsidiaries are involved in various legal actions in the normal course of business, in which claims for compensatory and punitive damages are asserted, some for substantial amounts.  We recognize an estimated loss from these loss contingencies when we believe it is probable that a loss has been incurred and the amount of the loss can be reasonably estimated. Some of the pending matters have been filed as purported class actions and some actions have been filed in certain jurisdictions that permit punitive damage awards that are disproportionate to the actual damages incurred.  The amounts sought in certain of these actions are often large or indeterminate and the ultimate outcome of certain actions is difficult to predict.  In the event of an adverse outcome in one or more of these matters, there is a possibility that the ultimate liability may be in excess of the liabilities we have established and could have a material adverse effect on our business, financial condition, results of operations and cash flows.  In addition, the resolution of pending or future litigation may involve modifications to the terms of outstanding insurance policies or could impact the timing and amount of rate increases, which could adversely affect the future profitability of the related insurance policies.  Based upon information presently available, and in light of legal, factual and other defenses available to the Company and its subsidiaries, the Company does not believe that it is probable that the ultimate liability from either pending or threatened legal actions, after consideration of existing loss provisions, will have a material adverse effect on the Company's consolidated financial condition, operating results or cash flows. However, given the inherent difficulty in predicting the outcome of legal proceedings, there exists the possibility that such legal actions could have a material adverse effect on the Company's consolidated financial condition, operating results or cash flows.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In addition to the inherent difficulty of predicting litigation outcomes, particularly those that will be decided by a jury, some matters purport to seek substantial or an unspecified amount of damages for unsubstantiated conduct spanning several years based on complex legal theories and damages models. The alleged damages typically are indeterminate or not factually supported in the complaint, and, in any event, the Company's experience indicates that monetary demands for damages often bear little relation to the ultimate loss. In some cases, plaintiffs are seeking to certify classes in the litigation and class certification either has been denied or is pending and we have filed oppositions to class certification or sought to decertify a prior class certification. In addition, for many of these cases: (i) there is uncertainty as to the outcome of pending appeals or motions; (ii) there are significant factual issues to be resolved; and/or (iii) there are novel legal issues presented. Accordingly, the Company cannot reasonably estimate the possible loss or range of loss in excess of amounts accrued, if any, or predict the timing of the eventual resolution of these matters.  The Company reviews these matters on an ongoing basis.  When assessing reasonably possible and probable outcomes, the Company bases its assessment on the expected ultimate outcome following all appeals.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On September 29, 2016, Washington National and Bankers Conseco Life Insurance Company ("BCLIC") commenced an arbitration proceeding seeking compensatory, consequential and punitive damages against BRe based upon BRe’s incurable material breaches of the long-term care reinsurance agreements, conversion, fraud, and breaches of fiduciary duties and the obligation to deal honestly and in good faith. BRe filed a counterclaim against Washington National and BCLIC in the arbitration alleging damages relating to the reinsurance agreements and their termination. In addition, on September 29, 2016, a complaint was filed by BCLIC and Washington National in the United States District Court for the Southern District of New York, Bankers Conseco Life Insurance Company and Washington National Insurance Company v. Moshe M. Feuer, Scott Taylor and David Levy, Case No. 16-cv-7646, alleging, among other claims, fraud/fraudulent concealment, and violation of the Racketeer Influenced and Corrupt Organizations Act. These allegations relate to the long-term care reinsurance agreements between BRe and Washington National and BCLIC, respectively, and emanate from the undisclosed relationships between and among the defendants (who were the principal owners and officers of BRe) and Platinum Partners, LP ("Platinum") and its affiliates. On April 27, 2017, an amended complaint was filed adding Beechwood Capital Group, LLC as a defendant. Feuer, Taylor and Levy have moved to compel arbitration of Washington National's and BCLIC's claims. Washington National and BCLIC intend to vigorously pursue their claims for damages and other remedies in the arbitration and the litigation described above.</font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By public notice dated July 26, 2017, the Cayman Islands Monetary Authority advised that, effective July 25, 2017, </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;"> individuals (the "Controllers") had been appointed pursuant to Section 24(2)(h) of the Cayman Islands Insurance Law to assume control of the affairs of BRe.  According to the public notice, effective with their appointment, the Controllers assumed immediate control of the affairs of BRe and have all the powers necessary to administer the affairs of BRe including power to terminate its insurance business.  The Controllers are responsible for assessing the financial position of BRe and submitting a report to the Cayman Islands Monetary Authority by a date to be specified.  We are in the process of assessing the potential impact of this action on the proceedings described in the foregoing paragraph.</font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On July 20, 2007, a complaint was filed in the Hamilton County, Indiana Circuit Court, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Signature Estates of Indiana, Inc. d/b/a Gordon Marketing, Stephens-Matthews Marketing, Inc., Shields Brokerage, Inc. and Edwin A. Hildebrand d/b/a Hildebrand Insurance Services v. Conseco Medical Insurance Company, Conseco Medical Insurance Company a/k/a Washington National Insurance Company and Washington National Insurance Company, Cause No. 29D02- 0707-PL-790.  </font><font style="font-family:inherit;font-size:10pt;">The Plaintiffs are independent insurance marketing organizations which previously marketed Conseco Medical Insurance Company ("CMIC") individual major medical products and which are claiming damages for allegedly fraudulent conduct by CMIC in withdrawing from this business in 2002.  The Plaintiffs contend that they relied on CMIC’s alleged representations that its major medical business was profitable and that CMIC was committed to it.  The Plaintiffs further allege that when CMIC exited the market, it caused agents that were previously writing business through their organizations to cease doing business with them, thereby causing irreparable damage.  CMIC merged into Washington National, effective July 1, 2003.  On December 16, 2016, following a jury trial, verdicts were entered in favor of the plaintiffs, and compensatory damages aggregating </font><font style="font-family:inherit;font-size:10pt;">$4.7 million</font><font style="font-family:inherit;font-size:10pt;"> and punitive damages aggregating </font><font style="font-family:inherit;font-size:10pt;">$6.0 million</font><font style="font-family:inherit;font-size:10pt;"> were awarded to the plaintiffs.  Washington National filed post-trial motions requesting the court correct errors, grant a new trial, find that punitive damages were improper, and reduce both compensatory and punitive damages.  Plaintiffs filed motions requesting pre-judgment interest and attorney fees.  On June 19, 2017, the court reduced punitive damages by </font><font style="font-family:inherit;font-size:10pt;">$1.5 million</font><font style="font-family:inherit;font-size:10pt;"> and denied plaintiffs' motions for pre-judgment interest and attorney fees. Both sides have filed a Notice of Appeal. We believe the case is without merit and intend to defend it vigorously.</font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Regulatory Examinations and Fines</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Insurance companies face significant risks related to regulatory investigations and actions.  Regulatory investigations generally result from matters related to sales or underwriting practices, payment of contingent or other sales commissions, claim payments and procedures, product design, product disclosure, additional premium charges for premiums paid on a periodic basis, denial or delay of benefits, charging excessive or impermissible fees on products, procedures related to canceling policies, changing the way cost of insurance charges are calculated for certain life insurance products or recommending unsuitable products to customers.  We are, in the ordinary course of our business, subject to various examinations, inquiries and information requests from state, federal and other authorities.  The ultimate outcome of these regulatory actions (including the costs of complying with information requests and policy reviews) cannot be predicted with certainty.  In the event of an unfavorable outcome in one or more of these matters, the ultimate liability may be in excess of liabilities we have established and we could suffer significant reputational harm as a result of these matters, which could also have a material adverse effect on our business, financial condition, results of operations or cash flows.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2011, we were notified of an examination to be done on behalf of a number of states for the purpose of determining compliance with unclaimed property laws by the Company and its subsidiaries.  Such examination has included inquiries related to the use of data available on the U.S. Social Security Administration's Death Master File to identify instances where benefits under life insurance policies, annuities and retained asset accounts are payable. We are continuing to provide information to the examiners in response to their requests. A total of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">38</font><font style="font-family:inherit;font-size:10pt;"> states and the District of Columbia are currently participating in this examination.</font></div></div>

Files In Submission

Name	View Source	Status
0001224608-17-000063-index-headers.html	Edgar Link	pending
0001224608-17-000063-index.html	Edgar Link	pending
0001224608-17-000063.txt	Edgar Link	pending
0001224608-17-000063-xbrl.zip	Edgar Link	pending
cno-20170930.xml	Edgar Link	completed
cno-20170930.xsd	Edgar Link	pending
cno-20170930_cal.xml	Edgar Link	unprocessable
cno-20170930_def.xml	Edgar Link	unprocessable
cno-20170930_lab.xml	Edgar Link	unprocessable
cno-20170930_pre.xml	Edgar Link	unprocessable
cno0930201710-q.htm	Edgar Link	pending
cno09302017ex101.htm	Edgar Link	pending
cno09302017ex102.htm	Edgar Link	pending
cno09302017ex103.htm	Edgar Link	pending
cno09302017ex104.htm	Edgar Link	pending
cno09302017ex105.htm	Edgar Link	pending
cno09302017ex106.htm	Edgar Link	pending
cno09302017ex107.htm	Edgar Link	pending
cno09302017ex121.htm	Edgar Link	pending
cno09302017ex311.htm	Edgar Link	pending
cno09302017ex312.htm	Edgar Link	pending
cno09302017ex321.htm	Edgar Link	pending
cno09302017ex322.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
orgchartclic.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CNO
CNO Financial Group, Inc. Stock $cno

2017 Q4 Form 10-Q Financial Statement

#000122460817000063 Filed on November 01, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CNO CNO Financial Group, Inc. Stock $cno

2017 Q4 Form 10-Q Financial Statement

#000122460817000063 Filed on November 01, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CNO
CNO Financial Group, Inc. Stock $cno